Advertisement

Topics

Redx Pharma calls a temporary halt to cancer trial to look at patient dosing

03:41 EDT 29 Mar 2018 | Proactive Investors

Chairman Iain Ross said he was confident the company could address issue

Original Article: Redx Pharma calls a temporary halt to cancer trial to look at patient dosing

NEXT ARTICLE

More From BioPortfolio on "Redx Pharma calls a temporary halt to cancer trial to look at patient dosing"

Advertisement
Quick Search
Advertisement
Advertisement